Literature DB >> 17169566

Vitamin A potently destabilizes preformed alpha-synuclein fibrils in vitro: implications for Lewy body diseases.

Kenjiro Ono1, Masahito Yamada.   

Abstract

Alpha-synuclein (alphaS) is the major component of the filamentous inclusions that constitute defining characteristics of Lewy body diseases (LBD) and multiple system atrophy (MSA). Clinically, antioxidant vitamins, such as vitamin E and the vitamin-like substance coenzyme Q10, have been used in the treatment of LBD with some efficacy. Using fluorescence spectroscopy with thioflavin S, electron microscopy and atomic force microscopy, here we examined the effects of ten antioxidant vitamins and vitamin-like substances, vitamin A (retinol, retinal and retinoic acid), beta-carotene, vitamins B2, B6, C, E, coenzyme Q10 and alpha-lipoic acid, on the formation of alphaS fibrils (falphaS) and on preformed falphaS. Among them, vitamin A, beta-carotene and coenzyme Q10 dose-dependently inhibited the formation of falphaS. Moreover, they also dose-dependently destabilized preformed falphaS. With such potent anti-fibrillogenic as well as fibril-destabilizing activities, these compounds could be useful in the treatment and prevention of LBD and MSA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17169566     DOI: 10.1016/j.nbd.2006.10.010

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  13 in total

Review 1.  The Oligomer Hypothesis in α-Synucleinopathy.

Authors:  Kenjiro Ono
Journal:  Neurochem Res       Date:  2017-08-21       Impact factor: 3.996

2.  Effects of saffron and its constituents, crocin-1, crocin-2, and crocetin on α-synuclein fibrils.

Authors:  Eiji Inoue; Yasuharu Shimizu; Ryo Masui; Tomomi Hayakawa; Tomoe Tsubonoya; Satoko Hori; Keiichi Sudoh
Journal:  J Nat Med       Date:  2017-11-17       Impact factor: 2.343

Review 3.  Dietary Antioxidants and Risk of Parkinson's Disease: A Systematic Review and Dose-Response Meta-analysis of Observational Studies.

Authors:  Sepide Talebi; Seyed Mojtaba Ghoreishy; Ahmad Jayedi; Nikolaj Travica; Hamed Mohammadi
Journal:  Adv Nutr       Date:  2022-10-02       Impact factor: 11.567

4.  Coenzyme Q10 effects in neurodegenerative disease.

Authors:  Meredith Spindler; M Flint Beal; Claire Henchcliffe
Journal:  Neuropsychiatr Dis Treat       Date:  2009-11-16       Impact factor: 2.570

5.  The Fox and the Rabbits-Environmental Variables and Population Genetics (1) Replication Problems in Association Studies and the Untapped Power of GWAS (2) Vitamin A Deficiency, Herpes Simplex Reactivation and Other Causes of Alzheimer's Disease.

Authors:  C J Carter
Journal:  ISRN Neurol       Date:  2011-07-12

Review 6.  Dietary factors in the etiology of Parkinson's disease.

Authors:  Zeynep S Agim; Jason R Cannon
Journal:  Biomed Res Int       Date:  2015-01-20       Impact factor: 3.411

Review 7.  Role of Dietary Supplements in the Management of Parkinson's Disease.

Authors:  Michele Ciulla; Lisa Marinelli; Ivana Cacciatore; Antonio Di Stefano
Journal:  Biomolecules       Date:  2019-07-10

8.  Partial peptide of α-synuclein modified with small-molecule inhibitors specifically inhibits amyloid fibrillation of α-synuclein.

Authors:  Wataru Yoshida; Natsuki Kobayashi; Yasuhiko Sasaki; Kazunori Ikebukuro; Koji Sode
Journal:  Int J Mol Sci       Date:  2013-01-28       Impact factor: 5.923

9.  Dietary antioxidants and risk of Parkinson's disease in two population-based cohorts.

Authors:  Fei Yang; Alicja Wolk; Niclas Håkansson; Nancy L Pedersen; Karin Wirdefeldt
Journal:  Mov Disord       Date:  2017-09-07       Impact factor: 10.338

10.  Systematic review of the literature on vitamin A and memory.

Authors:  Yara Dadalti Fragoso; Niklas Söderberg Campos; Breno Faria Tenrreiro; Fernanda Jussio Guillen
Journal:  Dement Neuropsychol       Date:  2012 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.